Canopy Biosciences is a biotechnology company specializing in spatial biology and multi-omics technologies. Founded in 2016 and headquartered in St. Louis, Missouri, the company focuses on advancing biomedical research through innovative tools and services.
Core Technologies and Services:
- CellScape™: A high-plex spatial proteomics platform that enables quantitative, multiplexed immunofluorescence imaging with single-cell resolution. This system is designed for comprehensive tissue analysis, supporting applications in immunology, oncology, and neuroscience.
- Spatial Transcriptomics: Utilizing technologies such as GeoMx® Digital Spatial Profiler and CosMx™ Spatial Molecular Imager, Canopy offers solutions for high-plex RNA and protein analysis, facilitating detailed tissue mapping and gene expression profiling.
- Gene Expression Analysis: The company provides services including single-cell RNA sequencing, targeted gene expression profiling, and nucleic acid extraction, aiding in-depth molecular characterization.
- Laboratory Pathology Services: Canopy offers histopathology, immunohistochemistry, and fluorescence in situ hybridization (FISH) services, supporting comprehensive tissue analysis and biomarker validation.
